Skip to main content

Table 6 Pilot study overall survival from randomisation

From: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible

Months Percentage surviving
6 68.5
12 50.0
18 35.2
24 31.3
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us